Investigating the role of minichromosome maintenance protein 2 in differentiating follicular adenoma from follicular carcinoma of thyroid
Abstract
Keywords
Full Text:
PDFReferences
Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am 96:329-349, 2012.
Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A. et al. Diagnostic utility of galectin‐3 and CD26/ DPPIV as preoperative diagnostic markers for thyroid nodules. Diagn Cytopathol 26:366-372, 2002.
Gharib H, Papini E, Paschke R. Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol 159:493-505, 2008.
Shaha AR. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. The Laryngoscope 114:393-402, 2004.
McHenry CR, Thomas SR, Slusarczyk SJ, Khiyami A. Follicular or Hürthle cell neoplasm of the thyroid: Can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery 126:798-804, 1999.
Saleh HA, Jin B, Barnwell J, Alzohaili O. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules. Diagn Pathol 5:9, 2010.
Bryson PC, Shores CG, Hart C, Thorne L, Patel MR, Richey L. et al. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Arch otorhinolaryngol- head neck surg 134:581-586, 2008.
Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. The Lancet 357:1644-1650, 2001.
Ciaputa R, Nowak M, Kandefer-Gola M, Dziedzic K, Halupka P, Pula B, et al. Morphological and immunohistological characteristics of follicular-compact thyroid carcinoma in dog. Folia Histochem Cytobiol 52:157-161, 2014.
Oestreicher‐Kedem Y, Halpern M, Roizman P, Hardy B, Sulkes J, Feinmesser R, et al. Diagnostic value of galectin‐3 as a marker for malignancy in follicular patterned thyroid lesions. Head & neck 26:960-966, 2004.
Papotti M, Rodriguez J, De Pompa R, Bartolazzi A, Rosai J. Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod Pathol 18:541-546, 2005.
Tumuluri V, Thomas GA, Fraser IS. Analysis of the Ki‐67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med 3:598-604, 2002.
Bologna-Molina R, Mosqueda Taylor A, Molina Frechero N, Mori Estevez AD, Sánchez Acuña G. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal 18:e174-9, 2013.
Akhtar M, Scognamiglio T. Minimally Invasive Follicular Carcinoma Versus Follicular Adenoma: MCM2 Proliferation Marker may be Helpful. Adv Anat Pathol 13:343, 2006.
Freeman A, Morris LS, Mills AD, Stoeber K, Laskey RA, Williams GH, et al. Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5:2121-2132, 1999.
Labib, Ramy, and Shiao-yng Chan. Patient with Thyroid Disease: Challenges and Management Options. In: Coomarasamy A, editor. Gynecologic and Obstetric Surgery: Challenges and Management Options, 1st edn. London: John Wiley & Sons; pp 30-32, 2016.
Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:901-911, 2008.
Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas: prevalence by palpation and ultrasonography. Arch Intern Med 154:1838-1840, 1994.
Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 126:226-231, 1997.
Mahfouz SM, AbdEl-Aal WE, Ali HHM, El-Habashi A, Esmail RSE. Galectin-3 and MCM2 expression in fine-needle aspiration cytology of thyroid nodules and their preoperative role in distinguishing benign from malignant thyroid lesions. Egypt J Pathol 32:245-255, 2012.
Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of Follicular Neoplasms, Atypia, and Lesions Suspicious for Malignancy Diagnosed by Fine-Needle Aspiration of Thyroid Nodules. Ann Surg 235:656–664, 2002.
Theodosiou Z, Kasampalidis IN, Livanos G, Zervakis M, Pitas I, Lyroudia K. Automated analysis of FISH and immunohistochemistry images: a review. Cytometry Part A 71:439-450, 2007.
Bilous M, Dowsett M, Hanna W, Isola J, Lebeau A,
Moreno A, Penault-Llorca F, Rüschoff J, Tomasic G, Van de Vijver M. Current perspectives on HER2 testing: a review of national testing guidelines. Mod Pathol 16:173-182, 2003.
Endl E, Gerdes J. The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231-237, 2000.
Mehrotra P, Gonzalez MA, Johnson SJ, Coleman N, Wilson JA, Davies BR, Lennard TW. Mcm‐2 and Ki‐67 Have Limited Potential in Preoperative Diagnosis of Thyroid Malignancy. The Laryngoscope 116:1434-1438, 2006.
Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue–a review. Diagn Pathol 9:221, 2014.
McHenry CR, Phitayakorn R. Follicular adenoma and carcinoma of the thyroid gland. The Oncologist 16:585–593, 2011.
Going JJ, Keith WN, Neilson L, Stoeber K, Stuart RC, Williams GH. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett`s mucosa. Gut 50:373-377, 2002.
Refbacks
- There are currently no refbacks.